Home | HAB Central

Honoraria Paymentss

Did you participate in a research study?

To retrieve your honoraria, click the sign-in link.from the menu at the top right of the page.

Article of the Day

FDA Approves Flortaucipir F18 to Image Tau Pathology in Alzheimer’s Disease

The US Food and Drug Administration (FDA) has approved flortaucipir F18 (Tauvid) for intravenous injection, the first drug used to help image tau pathology in Alzheimer’s disease. Flortaucipir F18 is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated...

See more articles

Journal Club

Endocrinology and Metabolism Clinics of North America

Endoscopic Treatments for Obesity: The Good, the Bad, and the Ugly

Egan, Vella

Journal of Diabetes and its Complications

The relationship of glycemic control, insulin dose, and race with hypoglycemia in youth with type 1 diabetes

Chalew, Kamps, Jurgen, et al.

See more abstracts

CME

Credits: 1.00 CME

Massachusetts Medical Society

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Credits: 0.50 CME

Oakstone Publishing

Is There a Window of Opportunity for Improved Outcomes in Acute Phase ACS: Making the Case for Early, Intensive LDL-C Lowering

Michael Davidson, MD, FACC, FNLA

See more education

HAB Central Earn honoraria and learn developments in medicine. For more than 25 years, the Healthcare Advisors Bureau (HAB) has gathered the opinions of professional healthcare providers.

Through HAB, the world of medicine has a respected and influential voice with government bodies, institutions, publishers, product manufacturers and providers of healthcare services.